These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2484927)

  • 21. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ; Charache S; Nora R; Boyer SH
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synthesis and chemical heterogeneity of human fetal hemoglobin: overview and present concepts.
    Schroeder WA
    Hemoglobin; 1980; 4(3-4):431-46. PubMed ID: 6158499
    [No Abstract]   [Full Text] [Related]  

  • 25. Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia.
    Ponnazhagan S; Sarkar R
    Indian J Pediatr; 1992; 59(1):85-90. PubMed ID: 1377179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling the fetal globin switch in man.
    Orkin SH
    Nature; 1983 Jan; 301(5896):108-9. PubMed ID: 6185847
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of fetal hemoglobin production.
    Kazazian HH
    Semin Hematol; 1974 Oct; 11(4):525-48. PubMed ID: 4608465
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation of beta to gamma synthesis during the first trimester: an approach to prenatal diagnosis of thalassemia.
    Cividalli G; Nathan DG; Kan YW; Santamarina B; Frigoletto F
    Pediatr Res; 1974 May; 8(5):553-60. PubMed ID: 4825524
    [No Abstract]   [Full Text] [Related]  

  • 31. Fetal hemoglobin levels in adults.
    Rochette J; Craig JE; Thein SL
    Blood Rev; 1994 Dec; 8(4):213-24. PubMed ID: 7534152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin biosynthesis in individual erythropoietic bursts in culture. Studies of adult peripheral blood.
    Kidoguchi K; Ogawa M; Karam JD
    J Clin Invest; 1979 Apr; 63(4):804-6. PubMed ID: 438339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
    J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT; Rodgers GP; Serjeant G; Schechter AN
    N Engl J Med; 1988 Jan; 318(2):96-9. PubMed ID: 2447498
    [No Abstract]   [Full Text] [Related]  

  • 38. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of fetal hemoglobin in the treatment of sickle cell disease.
    Fathallah H; Atweh GF
    Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New treatments of hemoglobinopathies].
    de Montalembert M
    Presse Med; 1997 Jun; 26(20):972-6. PubMed ID: 9238187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.